美国 · SEC FORM 4
InMed Pharmaceuticals Inc.
INM · Nasdaq · CIK 0001728328 · Healthcare · Drug Manufacturers—Specialty & Generic
内部人信号
66.4 / 100
2 位买方 · 46 条买入交易行 · $1.4M 买入总额
为什么有这个信号？
买方广度较低
买入规模中等
角色中等
近期性较强
确信度较强
评分构成
每条进度条表示其对当前分数的贡献；权重和公式保持不变。
Cluster+14.0 / 35
买入规模+18.9 / 25
角色+14.0 / 20
近期性+9.5 / 10
确信度+10.0 / 10
哪些因素限制了当前分数？
- ⚠ Cluster breadth is moderate · 2 insider(s), not 4+
- ⚠ 角色得分低 · 买入者中职位最高的是：TenPercentOwner（CEO、董事长和持股 10% 以上的股东得分最低）
- ✓ Recent activity · latest purchase 2026-10-15
Purchase-size comments are relative to the model scale. Average daily volume is a separate market-context diagnostic.
US-v1.2 按当前 180 天规则给合资格的股票买入打分。分数只表示研究的先后，不是收益预测或概率。回测没有显示美国分数越高、之后的表现越好。
内部人活动时间轴
申报人轨道展示最近 180 天。符号形状区分交易类型；卖出仅作为背景。
AprMayJunJulAugSepOct
Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLCTenPercentOwner
●●●●●●●●●●●●●●●
ADAR1 Capital Management, LLC; Schneeberger DanielTenPercentOwner
●●●●●●●●●●●●●●
● 买入▼ 卖出○ 其他
—
买方广度与集中度
合资格买方2
买入集中度68%最大买方： ADAR1 Capital Management, LLC; Schneeberger Daniel · $925.6K
聚集买入 · 15天2 insiders峰值活动： 2026-05-19–2026-06-03
Roles in the peak window: TenPercentOwner. Concentration uses priced qualifying P lines only and does not change the saved score.
信号历史
66.4 / 100
最新留档分数
↓ -0.3 pts相对上一个留档快照
- 66.1
- 66.0
- 65.8
- 66.7
- 66.4
Only scores saved when a full US scoring run completed are shown; gaps are not reconstructed.
近期 Form 4 活动
46买入
0卖出
0其他 Form 4 交易行
9SEC 申报 · 365天
买入46 qualifying P line(s) · 180 days
卖出0 sale line(s) · 仅供背景
其他0 exercise / withholding / award / gift / other lines
10b5-1／计划交易Not detected in parsed evidence
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
市场背景
市场背景补充近期价格表现与风险信息，不影响内部人信号。
价格表现
- 1M
- -5.0%
- 3M
- -13.2%
- 6M
- +85.9%
- 12M
- -40.0%
波动率与流动性
- 波动率
- 136.0%
- Beta
- —
- 平均每日成交额
- USD 1.2M
估值
- 市值
- —
- P/E
- —
基本面
- 利润率
- —
- ROE
- -1168.4%
- 细分行业
- Drug Manufacturers—Specialty & Generic
市场数据
价格数据截至：2026-10-18 · 价格来源：OpenBB/yfinance; 成交量来自 本机价格缓存 (yfinance) · 来自 SEC 申报文件：ROE · 财年截止日：2026-06-30 · Status: PASS
空头余额
空头余额是券商向 FINRA 申报的外部背景数据，不影响内部人信号。
- 空头股数
- 34,080
- 上期报告
- 15,876
- 日均成交量
- 78,901
- 回补天数
- ≤ 1.0
FINRA 结算日：2026-09-30 · 获取日期 2026-10-12 · FINRA 股票空头余额 ↗. 这是股数，每月两个结算日之后约一周公布；不是占已发行股份的比例。
历史股票买入
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 984 | USD 1.32 | USD 1,301 | SEC 申报 ↗ |
| 2026-10-14 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,021 | USD 1.33 | USD 10,668 | SEC 申报 ↗ |
| 2026-10-13 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 564 | USD 1.33 | USD 750 | SEC 申报 ↗ |
| 2026-10-08 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 2,256 | USD 1.33 | USD 2,997 | SEC 申报 ↗ |
| 2026-10-07 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 3,046 | USD 1.33 | USD 4,051 | SEC 申报 ↗ |
| 2026-10-06 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 5,601 | USD 1.33 | USD 7,436 | SEC 申报 ↗ |
| 2026-10-05 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 18,182 | USD 1.33 | USD 24,182 | SEC 申报 ↗ |
| 2026-10-02 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,307 | USD 1.33 | USD 11,048 | SEC 申报 ↗ |
| 2026-10-01 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 16,431 | USD 1.33 | USD 21,850 | SEC 申报 ↗ |
| 2026-09-16 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,340 | USD 1.29 | USD 10,759 | SEC 申报 ↗ |
| 2026-09-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 54,256 | USD 1.30 | USD 70,533 | SEC 申报 ↗ |
| 2026-09-14 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 28,505 | USD 1.29 | USD 36,771 | SEC 申报 ↗ |
| 2026-07-16 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 21 | USD 1.55 | USD 33 | SEC 申报 ↗ |
| 2026-07-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 1,000 | USD 1.56 | USD 1,560 | SEC 申报 ↗ |
| 2026-07-15 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 15,150 | USD 1.55 | USD 23,482 | SEC 申报 ↗ |
Form 4 申报证据
46 transaction lines in the latest 365-day window; 58 in local history.
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 984 | USD 1.32 | USD 1,301 | SEC 申报 ↗ |
| 2026-10-14 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,021 | USD 1.33 | USD 10,668 | SEC 申报 ↗ |
| 2026-10-13 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 564 | USD 1.33 | USD 750 | SEC 申报 ↗ |
展开近期 Form 4 证据 (29 grouped rows)
| 日期 | 申报人 | 类型 | 证券 | 股数 | 平均价格 | 估算金额 | 来源 |
|---|---|---|---|---|---|---|---|
| 2026-10-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 984 | USD 1.32 | USD 1,301 | SEC 申报 ↗ |
| 2026-10-14 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,021 | USD 1.33 | USD 10,668 | SEC 申报 ↗ |
| 2026-10-13 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 564 | USD 1.33 | USD 750 | SEC 申报 ↗ |
| 2026-10-08 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 2,256 | USD 1.33 | USD 2,997 | SEC 申报 ↗ |
| 2026-10-07 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 3,046 | USD 1.33 | USD 4,051 | SEC 申报 ↗ |
| 2026-10-06 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 5,601 | USD 1.33 | USD 7,436 | SEC 申报 ↗ |
| 2026-10-05 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 18,182 | USD 1.33 | USD 24,182 | SEC 申报 ↗ |
| 2026-10-02 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,307 | USD 1.33 | USD 11,048 | SEC 申报 ↗ |
| 2026-10-01 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 16,431 | USD 1.33 | USD 21,850 | SEC 申报 ↗ |
| 2026-09-16 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 8,340 | USD 1.29 | USD 10,759 | SEC 申报 ↗ |
| 2026-09-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 54,256 | USD 1.30 | USD 70,533 | SEC 申报 ↗ |
| 2026-09-14 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 28,505 | USD 1.29 | USD 36,771 | SEC 申报 ↗ |
| 2026-07-16 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 21 | USD 1.55 | USD 33 | SEC 申报 ↗ |
| 2026-07-15 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 1,000 | USD 1.56 | USD 1,560 | SEC 申报 ↗ |
| 2026-07-15 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 15,150 | USD 1.55 | USD 23,482 | SEC 申报 ↗ |
| 2026-07-14 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 5,375 | USD 1.55 | USD 8,331 | SEC 申报 ↗ |
| 2026-07-02 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 1,607 | USD 1.55 | USD 2,491 | SEC 申报 ↗ |
| 2026-07-01 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 4,344 | USD 1.55 | USD 6,733 | SEC 申报 ↗ |
| 2026-06-30 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 600 | USD 1.54 | USD 924 | SEC 申报 ↗ |
| 2026-06-08 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 32,500 | USD 1.52 | USD 49,400 | SEC 申报 ↗ |
| 2026-06-05 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 55,011 | USD 1.57 | USD 86,367 | SEC 申报 ↗ |
| 2026-06-04 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 6,743 | USD 1.57 | USD 10,587 | SEC 申报 ↗ |
| 2026-06-03 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 7,783 | USD 1.55 | USD 12,064 | SEC 申报 ↗ |
| 2026-06-02 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 22,848 | USD 1.52 | USD 34,729 | SEC 申报 ↗ |
| 2026-06-01 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 16,336 | USD 1.55 | USD 25,321 | SEC 申报 ↗ |
| 2026-05-29 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 17,796 | USD 1.57 | USD 27,940 | SEC 申报 ↗ |
| 2026-05-21 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 34,000 | USD 1.69 | USD 57,460 | SEC 申报 ↗ |
| 2026-05-20 | Vivo Opportunity Cayman Fund, L.P.; Vivo Opportunity Cayman, LLC; Vivo Opportunity Fund Holdings, L.P.; Vivo Opportunity, LLC | 买入 (P) | Common Shares | 56,210 | USD 1.56 | USD 87,688 | SEC 申报 ↗ |
| 2026-05-19 | ADAR1 Capital Management, LLC; Schneeberger Daniel | 买入 (P) | Common Shares | 468,551 | USD 1.54 | USD 721,682 | SEC 申报 ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
快照与身份
| 快照日期 | 2026-10-18 |
|---|---|
| 排名版本 | US-v1.2 |
| 数据质量 | PASS ELIGIBLE · — |
| 股票代码 | INM |
| CIK | 0001728328 |
| 行业 | Healthcare |
| 细分行业 | Drug Manufacturers—Specialty & Generic Yahoo Finance |
| SEC SIC | 2834 Pharmaceutical Preparations |
| 交易所 | Nasdaq |
数据覆盖
| 本地 Form 4 历史 | 58 transaction lines from 2021-09-28 to 2026-10-15 57 P purchase lines · 1 S sale lines · 0 other lines |
|---|---|
| SEC 公司申报 | 打开 SEC 申报 ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.